⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqCM

BLTE

Belite Bio, Inc

Healthcare · Biotechnology

183.16USD

-9.6900 (-5.02%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Fetching financial statements from SEC filings…

In $M except per-shareQ2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25
Revenue—————
Cost of Revenue—————
Gross Profit—————
Operating Income-35-33-28-23-18
Net Income-28-27-25-22-16
EPS (Diluted)$-0.70$-0.68$-0.70$-0.65$-0.50

Source: Yahoo Finance (limited history)